Vasopressin in critical illness: sometimes even old players leave a lot to discover

References 

1. Oliver G, Schaefer EA. On the physiological action of extract of pituitary body and certain other glandular organs. The Journal of physiology. 1895;18:277–279
   • MEDLINE
2. Dekanski J. The quantitative assay of vasopressin. British Journal of Pharmacology and Chemotherapy. 1952;7(4):567–572
   • MEDLINE
3. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122–1125
   • MEDLINE
4. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Critical Care Medicine. 1997;25(8):1279–1282
   • MEDLINE
   • CrossRef
5. Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. The New England journal of medicine. 2004;350(2):105–113
   • CrossRef
6. Russell JA, Walley KR, Singer J, et al. A randomized controlled trial of low dose vasopressin versus norepinephrine infusion in patients who have septic shock. American Journal of Respiratory and Critical Care Medicine. 2006;175(Suppl.):A508
7. Stroumpoulis K, Xanthos T, Rokas G, et al. Vasopressin and epinephrine in the treatment of cardiac arrest: an experimental study. Critical care. 2008;12(2):R40
8. Morelli A, Ertmer C, Lange M, Westphal M. Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?. Intensive Care Medicine. 2007;33(9):1669–1670
9. Morelli A, Ertmer C, Lange M, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. British Journal of Anaesthesia. 2008;100(4):494–503
   • CrossRef
10. Lange M, Morelli A, Ertmer C, et al. Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock. 2007;28(5):623–629
11. Yildizdas D, Yapicioglu H, Celik U, et al. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Medicine. 2008;34(3):511–517
    • CrossRef
12. de Kruif MD, Lemaire LC, Giebelen IA, et al. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Medicine. 2008;34(3):518–522
    • CrossRef
13. Rehberg S, Ertmer C, Lange M, et al. Vasopressin and terlipressin as first-line therapy in fulminant ovine septic shock. [abstract] Critical care. 2008;12(Suppl. 2):P405
14. Morelli A, Ertmer C, Lange M, et al. Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study. [abstract] Critical care. 2008;12(Suppl. 2):P403
15. Semenas E, Wiklund L. Levosimendan does not improve resuscitation success after hypovolemic cardiac arrest. Critical care. 2008;12(Suppl. 2):P265
16. Hauser B, Giudici R, Simon F, et al. Glucose metabolism during hyperdynamic septic shock: comparison between noradrenaline and vasopressin. [abstract] Critical care. 2008;12(Suppl. 2):P402
17. Fathallah B, Bel Hadj Amor M, Hichri N, et al. Hemodynamic effects of association of vasopressin and norepinephrine in patients with septic shock. [abstract] Critical care. 2008;12(Suppl. 2):P404
18. Hajjar L, Ticom T, Magro M, et al. Terlipressin in catecholamine-resistant hyperdynamic shock patients after cardiac surgery. [abstract] Critical care. 2008;12(Suppl. 2):P406
19. Laporte R, Russell J, Landry D, Riviere P. Selective V1a receptor agonist FE 202158 reverses platelet-activating factor-induced hypotension, vascular leak, impaired tissue perfusion, and mortality in rats. [abstract] Critical care. 2008;12(Suppl. 2):P407
20. Traber D. Selective V1a receptor agonists in experimental septic shock. [abstract] Critical care. 2007;11(Suppl. 4):P51
21. Gordon AC, Russell JA, Holmes CL, et al. The effect of vasopressin on acute renal failure in septic shock. American Journal of Respiratory and Critical Care Medicine. 2006;175(Suppl.):A596